The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema
Purpose: To evaluate the influence of pars plana vitrectomy with internal limiting membrane peeling on recurrence time of diabetic macular edema in eyes under treatment with dexamethasone intravitreal implant injections. Material and methods: Twelve pseudophakic eyes of 12 patients with non-prolifer...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | American Journal of Ophthalmology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993622001475 |
_version_ | 1817980474526531584 |
---|---|
author | Elia Franzolin Elena Gusson Giacomo Panozzo |
author_facet | Elia Franzolin Elena Gusson Giacomo Panozzo |
author_sort | Elia Franzolin |
collection | DOAJ |
description | Purpose: To evaluate the influence of pars plana vitrectomy with internal limiting membrane peeling on recurrence time of diabetic macular edema in eyes under treatment with dexamethasone intravitreal implant injections. Material and methods: Twelve pseudophakic eyes of 12 patients with non-proliferative diabetic retinopathy and non-tractional diabetic macular edema were included. All eyes had already been treated with two or more dexamethasone intravitreal implant injections evidencing a recurrence time of three months or less (early recurrence). At baseline, they underwent pars plana vitrectomy with internal limiting membrane peeling, ending with dexamethasone intravitreal implant injection. Patients were then followed-up monthly, treated with a second injection at the first recurrence, and followed up to the second recurrence. Measurements of best corrected visual acuity, intraocular pressure, and central foveal thickness by spectral-domain optical coherence tomography were performed at each follow-up examination. Results: Vitrectomized eyes showed a significant extension of recurrence time of diabetic macular edema, and specifically from 3.4 (3.2–3.7) to 6.5 (5.7–8.2) months after the first injection, and to 7.0 (5.7–8.2) months (p < 0.01) after the second injection (p < 0.01). Conclusions and importance: Pars plana vitrectomy with internal limiting membrane peeling seems not to influence functional and anatomical results in eyes under treatment with dexamethasone intravitreal implant injections for diabetic macular edema, but appears to significantly extend the benefit of the drug. |
first_indexed | 2024-04-13T22:54:10Z |
format | Article |
id | doaj.art-a0d178af15134cb3a885016a65e990e1 |
institution | Directory Open Access Journal |
issn | 2451-9936 |
language | English |
last_indexed | 2024-04-13T22:54:10Z |
publishDate | 2022-06-01 |
publisher | Elsevier |
record_format | Article |
series | American Journal of Ophthalmology Case Reports |
spelling | doaj.art-a0d178af15134cb3a885016a65e990e12022-12-22T02:26:05ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362022-06-0126101401The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edemaElia Franzolin0Elena Gusson1Giacomo Panozzo2Ophthalmic Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy; Corresponding author. Ophthalmic Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le L. A. Scuro 10, 37134, Verona, Italy.Ophthalmic Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, ItalyDepartment of Ophthalmology, Bussolengo Civil Hospital, Verona, ItalyPurpose: To evaluate the influence of pars plana vitrectomy with internal limiting membrane peeling on recurrence time of diabetic macular edema in eyes under treatment with dexamethasone intravitreal implant injections. Material and methods: Twelve pseudophakic eyes of 12 patients with non-proliferative diabetic retinopathy and non-tractional diabetic macular edema were included. All eyes had already been treated with two or more dexamethasone intravitreal implant injections evidencing a recurrence time of three months or less (early recurrence). At baseline, they underwent pars plana vitrectomy with internal limiting membrane peeling, ending with dexamethasone intravitreal implant injection. Patients were then followed-up monthly, treated with a second injection at the first recurrence, and followed up to the second recurrence. Measurements of best corrected visual acuity, intraocular pressure, and central foveal thickness by spectral-domain optical coherence tomography were performed at each follow-up examination. Results: Vitrectomized eyes showed a significant extension of recurrence time of diabetic macular edema, and specifically from 3.4 (3.2–3.7) to 6.5 (5.7–8.2) months after the first injection, and to 7.0 (5.7–8.2) months (p < 0.01) after the second injection (p < 0.01). Conclusions and importance: Pars plana vitrectomy with internal limiting membrane peeling seems not to influence functional and anatomical results in eyes under treatment with dexamethasone intravitreal implant injections for diabetic macular edema, but appears to significantly extend the benefit of the drug.http://www.sciencedirect.com/science/article/pii/S2451993622001475Dexamethasone intravitreal implantDiabetesDiabetic macular edemaInternal limiting membrane peelingPars plana vitrectomy |
spellingShingle | Elia Franzolin Elena Gusson Giacomo Panozzo The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema American Journal of Ophthalmology Case Reports Dexamethasone intravitreal implant Diabetes Diabetic macular edema Internal limiting membrane peeling Pars plana vitrectomy |
title | The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema |
title_full | The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema |
title_fullStr | The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema |
title_full_unstemmed | The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema |
title_short | The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema |
title_sort | effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema |
topic | Dexamethasone intravitreal implant Diabetes Diabetic macular edema Internal limiting membrane peeling Pars plana vitrectomy |
url | http://www.sciencedirect.com/science/article/pii/S2451993622001475 |
work_keys_str_mv | AT eliafranzolin theeffectofparsplanavitrectomywithinternallimitingmembranepeelingonthedurabilityoftheintravitrealdexamethasoneimplantinthetreatmentofdiabeticmacularedema AT elenagusson theeffectofparsplanavitrectomywithinternallimitingmembranepeelingonthedurabilityoftheintravitrealdexamethasoneimplantinthetreatmentofdiabeticmacularedema AT giacomopanozzo theeffectofparsplanavitrectomywithinternallimitingmembranepeelingonthedurabilityoftheintravitrealdexamethasoneimplantinthetreatmentofdiabeticmacularedema AT eliafranzolin effectofparsplanavitrectomywithinternallimitingmembranepeelingonthedurabilityoftheintravitrealdexamethasoneimplantinthetreatmentofdiabeticmacularedema AT elenagusson effectofparsplanavitrectomywithinternallimitingmembranepeelingonthedurabilityoftheintravitrealdexamethasoneimplantinthetreatmentofdiabeticmacularedema AT giacomopanozzo effectofparsplanavitrectomywithinternallimitingmembranepeelingonthedurabilityoftheintravitrealdexamethasoneimplantinthetreatmentofdiabeticmacularedema |